Anti-nausea agent beginning Phase III trials

OPKO Health Inc has announced it is launching a trio of Phase III clinical trials to evaluate how effective their drug Rolapitant® is in dealing with Chemotherapy-Induced Nausea and Vomiting (CINV).

Rolapitant is a Neurokinin-1 (NK-1) receptor antagonist being developed by OPKO and TESARO for patients receiving chemotherapy regimens that are typically known to induce nausea and vomiting to one degree or another.

The company will be running a pair of randomized, double-blind and placebo-controlled clinical trials evaluating the efficacy of a single 200mg oral dose of rolapitant in patients being given highly emetogenic chemotherapy, or HEC. Enrollment for each trial is expected to be around 530 patients, or over 1,000 in all.

The third trial will evaluate the efficacy of a single 200mg oral dose of rolapitant in patients receiving moderately emetogenic chemotherapy, or MEC. This trial will recruit 2,400 cancer patients.

Results are expected sometime in 2013. Currently, rolapitant is an investigational agent only, and not approved by the FDA or any other known regulatory agencies.

Source: Therapeutics Daily

More Articles

More Articles

Lymphoma patients may have the option to participate in clinical trials, gaining access to an experimental treatment before it is widely available...

Since there are several subtypes of T cell lymphoma, there will necessarily be several non-specific T cell lymphoma...

In order to prevent developing any subtype of lymphoma, it would be helpful to know the causes of lymphoma. Unfortunately, in virtually every case...

After surviving lymphoma treatments, patients should be on the lookout for late effects. These are symptoms that arise well after treatment has...

Canine lymphoma is a fairly common cancer in American dogs. The most commonly seen lymphoma in America is a type called Lymphosarcoma, although...

Advances in the treatment of Hodgkin's lymphoma have resulted in remarkable survival rates, even for...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...

The short answer: both. Let's begin with a simple definition of radiation: Radiation is the energy emitted from an energy source. That energy...

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

When you consider that the adult human body has anywhere from 300 to 700 lymph nodes, the better question might not be where ARE they located, but...

This entry looks at a non-Hodgkin's lymphoma called true histiocytic lymphoma (THL), also referred to as diffuse histiocytic lymphoma, and...

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Intravascular lymphoma is a subtype of 'Lymphoma', an umbrella term that loosely refers to several dozen...